PubMed Health⌕ Search

PubMed · 11944546

[Aphthous stomatitis].

Abstract

Aphthous stomatitis remains an illness of unknown aetiology, probably drawing on immunological mechanisms. The diagnosis of an oral aphthous ulcer is clinical, corresponding to a precise primary lesion. The benign form is the most frequent, however the illness sometimes evolves into a severe form which can then be considered as a generalised illness. The management of the patient must distinguish the evolving clinical form of the aphthous ulcer, search for a likely aetiology, and employ a therapeutic approach, which actually remains disappointing with the basic treatments being of solely temporary efficacity.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Scarlette Agbo-Godeau. 2002-02-15. [Aphthous stomatitis].. https://pubmed.ncbi.nlm.nih.gov/11944546/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Synergism between rViscumin and cisplatin is not dependent on ERCC-1 expression.

Interactions between recombinant mistletoe lectin (rViscumin) and anticancer drugs were investigated in vitro. rViscumin enhanced the cytotoxic effects of vincristine, mafosfamide, idarubicin and cisplatin in the human leukemia cell lines K562 and KG1a. In human marrow progenitor cells, rViscumin inhibited colony formation and did not exert any protective activity against cisplatin-induced inhibition of clonogenicity. Quantitative real-time reverse transcription polymerase chain reaction analysis revealed that cisplatin treatment of K562 cells resulted in a 1.9-fold increase in mRNA expression of the nucleotide excision repair gene ERCC-1. This upregulation was not prevented when cells were post-incubated with rViscumin. Our study provides evidence that rViscumin is capable of enhancing cytotoxicity of anticancer agents in vitro. This synergism appears to be independent of transcriptional activity of DNA repair relevant genes.

Adjuvants, Immunologic↗